Par Pharmaceutical Companies, Inc. (NYSE:PRX)‎ announced that it is being acquired by Private equity firm TPG in a deal that is worth roughly $1.9 billion.

• Do you own shares of Par Pharmaceutical Companies, Inc. (NYSE:PRX)?

• Did you buy PRX shares before July 16, 2012?

• Do you think that the proposed deal is unfair to Par Pharmaceutical Companies, Inc. (NYSE:PRX) shareholders? Is $50 in cash too low for Par Pharmaceutical Companies, Inc. (NYSE:PRX)?

Think this deal is unfair? Call 1-800-934-2921 right now to protect your rights.

If you own any amount of PRX shares, contact our law firm today to protect your rights.

Don't like the prospect of this deal? Our law firm is investigating potential claims against the board of directors of PRX concerning possible breaches of fiduciary duty and other violations of securities laws related to the agreement to be being purchased by Private equity firm TPG in a deal that is worth roughly $1.9 billion.

Own PRX stock?

If you are a shareholder of any amount of PRX complete the form on this page or call Attorney Bill Kyros at 1-800-934-2921 to discuss your rights.

Kyros Law LLP is a Boston-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions.